## EQIX: Equinix, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -8.4% below STRENGTH zone (4.0-10.0%); PEG 2.90 fails VALUE criteria (<1.0); RSI 27 oversold (REVERSION excluded per A/B test). Stock is in no-man's land without clear edge. Caution: momentum weakening (-2.5% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($691.32)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. HALPER SADEH LLC ENCOURAGES EQUINIX, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS**
- Source: Morningstar | 20251130T202900 | Neutral | Relevance: 99%
-  Halper Sadeh LLC, an investor rights law firm, is investigating potential breaches of fiduciary duties by certain officers and directors of Equinix, Inc. The firm encourages Equinix (NASDAQ: EQIX) shareholders to contact them to discuss their rights, which may include seeking corporate governance reforms or financial relief. Shareholder involvement is highlighted as a way to improve company policies and enhance shareholder value.

**2. Bronstein, Gewirtz & Grossman, LLC Is Investigating Equinix, Inc. (EQIX) And Encourages Stockholders to Connect**
- Source: WREG.com | 20251202T110000 | Neutral | Relevance: 99%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equinix, Inc. (NASDAQ:EQIX). The investigation focuses on whether Equinix and its officers/directors engaged in corporate wrongdoing, specifically concerning investors who purchased securities prior to May 3, 2019, and continue to hold them. The firm encourages affected stockholders to connect to assist with the investigation.

**3. Does the Recent Expansion News Signal a Value Opportunity for Equinix in 2025?**
- Source: Simply Wall Street | 20251202T075027 | Somewhat-Bullish | Relevance: 99%
- This article analyzes whether Equinix presents a value opportunity in 2025 by examining its recent expansion news, stock performance, and valuation using Discounted Cash Flow (DCF) and Price-to-Earnings (PE) ratio analyses. While the DCF analysis suggests Equinix is significantly undervalued, the PE ratio indicates it is overvalued compared to its industry and peers. The article also introduces "Narratives" as a tool for investors to customize valuation based on their own expectations.

**4. Equinix, Inc. (EQIX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation**
- Source: Eyewitness News (WEHT/WTVW) | 20251130T160000 | Neutral | Relevance: 99%
- Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Equinix, Inc. (NASDAQ:EQIX). The firm encourages stockholders who purchased Equinix securities before May 3, 2019, and still hold them, to contact them regarding the investigation. The inquiry aims to determine if Equinix and its officers/directors engaged in illegal activities.

**5. Equinix, Inc. (EQIX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation**
- Source: KLAS 8 News Now | 20251130T160000 | Neutral | Relevance: 98%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Equinix, Inc. (NASDAQ:EQIX) on behalf of investors who purchased securities prior to May 3, 2019, and continue to hold them. The investigation concerns potential corporate wrongdoing by Equinix and its officers or directors. The firm encourages affected stockholders to contact them to learn more and assist the investigation.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | BMO Capital | $900 | $900 | 0% |
| 2025-11-18 | Truist Securiti | $973 | $961 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | BMO Capital | up | Outperform |
| 2025-11-18 | Truist Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.00M) |
| Sells | 10 ($0.35M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.5% (+1.2%)
- Blackrock Inc.: 11.0% (-1.1%)
- State Street Corpora: 6.4% (+0.2%)
- JPMORGAN CHASE & CO: 5.9% (+151.6%)
- FMR, LLC: 2.7% (+12.7%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.5% 5d) with bearish MACD, trend may be turning.
2. Premium valuation (P/E 48x, PEG 2.9x) vulnerable to multiple compression.
3. Long-term trend broken: trading 11.2% below SMA200.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.90 signals overvaluation risk, limited margin of safety. Forward P/E 47.8x stretched relative to 1% growth. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $72.1B |
| Beta | 1.04 |
| 52W Range | $701.41 - $986.50 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.90 |
| Forward P/E | 47.8 |
| Current P/E | 48.2 |
| YoY Growth | 0.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from -5.9% to -8.4% (-2.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 12.4pp (needs >4.0% for momentum thesis). AM_20 at -6.8% indicates price below own 20MA trend. Underperforming sector by 6.6pp, stock-specific weakness. Below SMA200 (0.89x), long-term trend not supportive. MACD histogram bearish (-5.69), momentum weakening. RSI oversold at 27, potential bounce setup.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -8.42% (CS: 4) | Weak |
| RSI_14 | 27.2 | Oversold |
| MACD Histogram | -5.69 | Bearish |
| vs SMA20 | 0.931x | Below |
| vs SMA50 | 0.912x | Below |
| vs SMA200 | 0.888x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $727.38
- **Stop Loss:** $691.32 (5.0% risk)
- **Target:** $763.44 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 13
- **Position Value:** $9,455.94
- **Portfolio %:** 9.46%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-11 (Est: $3.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.43 | $3.89 | +13.1% |
| 2025Q2 | $3.44 | $3.79 | +10.3% |
| 2025Q1 | $2.97 | $3.59 | +20.8% |
| 2024Q4 | $2.74 | $2.97 | +8.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*